Presentation is loading. Please wait.

Presentation is loading. Please wait.

Prognostic Value of Undetectable hs Troponin T in Suspected Acute Coronary Syndrome  Mehrshad Vafaie, MD, Anna Slagman, VD, MSc, Martin Möckel, MD, PhD,

Published byKarl Reuter Modified over 5 years ago

Similar presentations

Presentation on theme: "Prognostic Value of Undetectable hs Troponin T in Suspected Acute Coronary Syndrome  Mehrshad Vafaie, MD, Anna Slagman, VD, MSc, Martin Möckel, MD, PhD,"— Presentation transcript:

1 Prognostic Value of Undetectable hs Troponin T in Suspected Acute Coronary Syndrome 
Mehrshad Vafaie, MD, Anna Slagman, VD, MSc, Martin Möckel, MD, PhD, Christian Hamm, MD, PhD, Kurt Huber, MD, PhD, Christian Müller, MD, Jörn O. Vollert, MD, MBA, Stefan Blankenberg, MD, PhD, Hugo A. Katus, MD, PhD, Christoph Liebetrau, MD, Evangelos Giannitsis, MD, PhD, Julia Searle, MD, MPH  The American Journal of Medicine  Volume 129, Issue 3, Pages e2 (March 2016) DOI: /j.amjmed Copyright © 2016 Elsevier Inc. Terms and Conditions

2 Figure 1 Patient flow. In the Biomarkers in Cardiology (BIC)-8 main trial, 902 patients were enrolled. Of these, 20 patients did not have high-sensitivity troponin T (hsTnT) or copeptin values available at admission. Thus, the study population of this BIC-8 substudy consists of 882 patients with complete biomarker results at admission. Patients were divided by their biomarker test. Relative and absolute frequencies are shown in the respective boxes. The American Journal of Medicine  , e2DOI: ( /j.amjmed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

3 Figure 2 Hazards over time as a result of Kaplan-Meier analysis in high-sensitivity troponin T (hsTnT) and copeptin subgroups. The results of a Kaplan-Meier survival analysis are depicted. Hazards over time are shown for 3 biomarker-related subgroups: 1) hsTnT below limit of detection (LoD) (<5 ng/L), 2) hsTnT low (5 < 14 ng/L), and copeptin negative (<10 pmol/L) and 3) hsTnT low (5 < 14 ng/L) and copeptin positive (≥10 pmol/L). CI = confidence interval; HR = hazard ratio. The American Journal of Medicine  , e2DOI: ( /j.amjmed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

4 Figure 3 Hazard ratios (HRs) from univariate proportional hazards regression analysis for the combined endpoint (death and myocardial infarction) as well as for single endpoint components: 1) high-sensitivity troponin T (hsTnT) in 3 categories (<5 ng/L, 5 < 14 ng/L, and ≥14 ng/L); reference category is hsTnT < 5 ng/L. 2) Copeptin in 2 categories (<10 pmol/L and ≥10 pmol/L); reference category is copeptin < 10 pmol/L. 3) Copeptin in patients with hsTnT below the limit of detection and 4) hsTnT 5 < 14 ng/L; the reference category is copeptin < 10 pmol/L. 5) Copeptin in patients with hsTnT at or above 14 ng/L; reference category is copeptin < 10 pmol/L. 6) HsTnT and copeptin combined in 5 categories (a: hsTnT < 5 ng/L, b: hsTnT 5 < 14 ng/L and copeptin < 10 pmol/L, c: hsTnT 5 < 14 ng/L and copeptin ≥ 10 pmol/lL, d: hsTnT ≥ 14 ng/L and copeptin < 10 pmol/L, e: hsTnT ≥ 14 ng/L and copeptin ≥ 10 pmol/L). Reference category in this analysis was the lowest risk category (hsTnT < 5 ng/L) and HRs can be interpreted as per increase in one category. nmiss = number of missing values. CI = confidence interval; HR = hazard ratio; MI = myocardial infarction. The American Journal of Medicine  , e2DOI: ( /j.amjmed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

5 Figure 4 Potential algorithm. This figure summarizes the potential use of high-sensitivity troponin T (hsTnT) below the limit of detection (LoD) based on a postrandomization cohort of the randomized Biomarkers in Cardiology (BIC)-8 process study. It is proposed that one hsTnT value < LoD alone may be sufficient for safe discharge from the emergency department (ED). This strategy, however, should be tested prospectively before implementation in clinical routine. Copeptin may be useful in patients with detectable hsTnT levels below the 99th percentile cut-off, copeptin values below 10 pmol/L may indicate a low risk and could potentially be part of an early rule-out strategy in these patients. The American Journal of Medicine  , e2DOI: ( /j.amjmed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

6 Supplementary Figure 1 Hazards over time as a result of Kaplan-Meier-Analysis in hsTnT subgroups. CI = confidence interval; HR = hazard ratio; hsTnT = high-sensitivity troponin T. The American Journal of Medicine  , e2DOI: ( /j.amjmed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

7 Supplementary Figure 2 Receiver operating curve analysis in all patients. hsTnT = high-sensitivity troponin T. The American Journal of Medicine  , e2DOI: ( /j.amjmed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

Download ppt "Prognostic Value of Undetectable hs Troponin T in Suspected Acute Coronary Syndrome  Mehrshad Vafaie, MD, Anna Slagman, VD, MSc, Martin Möckel, MD, PhD,"

Similar presentations

The Epidemic of the 20th Century: Coronary Heart Disease

The Epidemic of the 20th Century: Coronary Heart Disease
B-type Natriuretic Peptide in the Early Diagnosis and Risk Stratification of Acute Chest Pain  Philip Haaf, MD, Tobias Reichlin, MD, Nils Corson, MD,

B-type Natriuretic Peptide in the Early Diagnosis and Risk Stratification of Acute Chest Pain  Philip Haaf, MD, Tobias Reichlin, MD, Nils Corson, MD,
Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort  Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Axel.

Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort  Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Axel.
Effects of structured care by a pharmacist-diabetes specialist team in patients with Type 2 diabetic nephropathy  Wilson Y.S. Leung, BPharm, PhD, Wing-Yee.

Effects of structured care by a pharmacist-diabetes specialist team in patients with Type 2 diabetic nephropathy  Wilson Y.S. Leung, BPharm, PhD, Wing-Yee.
One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I  Cedric Jaeger, MD, Karin Wildi, MD, Raphael Twerenbold,

One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I  Cedric Jaeger, MD, Karin Wildi, MD, Raphael Twerenbold,
The Effect of Smoking on the Risk of Sciatica: A Meta-analysis

The Effect of Smoking on the Risk of Sciatica: A Meta-analysis
Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention  Chirag Bavishi, MD, MPH,

Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention  Chirag Bavishi, MD, MPH,
Masaya Koshizaka, MD, PhD, Renato D. Lopes, MD, PhD, MHS, L

Masaya Koshizaka, MD, PhD, Renato D. Lopes, MD, PhD, MHS, L
Impact of More Restrictive Blood Transfusion Strategies on Clinical Outcomes: A Meta- analysis and Systematic Review  Shelley R. Salpeter, MD, Jacob S.

Impact of More Restrictive Blood Transfusion Strategies on Clinical Outcomes: A Meta- analysis and Systematic Review  Shelley R. Salpeter, MD, Jacob S.
‘Chest Pain Typicality’ in Suspected Acute Coronary Syndromes and the Impact of Clinical Experience  Edward W. Carlton, MBChB, Martin Than, MBBS, Louise.

‘Chest Pain Typicality’ in Suspected Acute Coronary Syndromes and the Impact of Clinical Experience  Edward W. Carlton, MBChB, Martin Than, MBBS, Louise.
Identifying Patients Suitable for Discharge After a Single-Presentation High-Sensitivity Troponin Result: A Comparison of Five Established Risk Scores.

Identifying Patients Suitable for Discharge After a Single-Presentation High-Sensitivity Troponin Result: A Comparison of Five Established Risk Scores.
Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction  Stein Ørn, MD, John G.F. Cleland, MD, Matti.

Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction  Stein Ørn, MD, John G.F. Cleland, MD, Matti.
Significance of Elevated Cardiac Troponin T Levels in Critically Ill Patients with Acute Respiratory Disease  Vlad C. Vasile, MD, PhD, High-Seng Chai,

Significance of Elevated Cardiac Troponin T Levels in Critically Ill Patients with Acute Respiratory Disease  Vlad C. Vasile, MD, PhD, High-Seng Chai,
Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease  Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,

Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease  Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,
Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis  Islam Y. Elgendy,

Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis  Islam Y. Elgendy,
B-type Natriuretic Peptide in the Early Diagnosis and Risk Stratification of Acute Chest Pain  Philip Haaf, MD, Tobias Reichlin, MD, Nils Corson, MD,

B-type Natriuretic Peptide in the Early Diagnosis and Risk Stratification of Acute Chest Pain  Philip Haaf, MD, Tobias Reichlin, MD, Nils Corson, MD,
Matthew I. Worthley, MBBS, PhD, FRACP, Fiona M

Matthew I. Worthley, MBBS, PhD, FRACP, Fiona M
30-Day Readmissions After an Acute Kidney Injury Hospitalization

30-Day Readmissions After an Acute Kidney Injury Hospitalization
Digoxin Use and Lower 30-day All-cause Readmission for Medicare Beneficiaries Hospitalized for Heart Failure  Ali Ahmed, MD, MPH, Robert C. Bourge, MD,

Digoxin Use and Lower 30-day All-cause Readmission for Medicare Beneficiaries Hospitalized for Heart Failure  Ali Ahmed, MD, MPH, Robert C. Bourge, MD,
Prognostic Value of Low Blood Glucose at the Presentation of E

Prognostic Value of Low Blood Glucose at the Presentation of E

Similar presentations

Ads by Google